In an effort find new treatment therapies for breast cancer, researchers have begun to study cannabidiol, or CBD. Cannabidiol is one of the major non-psychoactive components of the hemp plant. CBD has become increasingly popular to treat a wide variety of ailments do to its ability to regulate the body’s endocannabinoid system. Preliminary research has shown CBD to be an effective, targeted and non-toxic option that could regulate the metastatic properties of breast and other cancers.
At the California Pacific Medical Center in San Francisco, California, researchers had previously reported that cannabidiol exhibits a very low toxicity profile and effectively down-regulates the Id-1 gene expression in breast cancer cells in cultures. Their continued research has shown that the down-regulation of Id-1 by CBD also inhibits the proliferative and invasive phenotype of breast cancer cells. Their studies have also shown that CBD therapy effectively reduces the primary tumor mass, as well as, the size and frequency of metastases in mice.
The important research being done at the California Pacific Medical Center further proves how significant CBD could be to the medical community. We eagerly await further studies demonstrating the effects cannabidiol has on cancer cells.
To read more about the study referenced above, please see here.